 Michael Yaron
Concepts (613)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sjogren's Syndrome | 17 | 2001 | 42 | 1.880 |
Why?
| | Arthritis, Rheumatoid | 44 | 2006 | 1003 | 1.690 |
Why?
| | Altitude Sickness | 9 | 2015 | 152 | 1.280 |
Why?
| | Methotrexate | 15 | 1997 | 228 | 0.930 |
Why?
| | Synovial Membrane | 10 | 2003 | 74 | 0.920 |
Why?
| | Osteoarthritis | 12 | 2003 | 173 | 0.910 |
Why?
| | Saliva | 7 | 2001 | 189 | 0.890 |
Why?
| | Interleukin-1 | 11 | 2004 | 971 | 0.800 |
Why?
| | Hyaluronic Acid | 12 | 2001 | 190 | 0.780 |
Why?
| | Balneology | 4 | 2000 | 4 | 0.530 |
Why?
| | Antibodies, Antinuclear | 7 | 2001 | 60 | 0.520 |
Why?
| | Middle Aged | 86 | 2015 | 27078 | 0.500 |
Why?
| | Interleukin-6 | 6 | 2006 | 677 | 0.490 |
Why?
| | Surveys and Questionnaires | 7 | 2010 | 4673 | 0.480 |
Why?
| | Female | 114 | 2015 | 60070 | 0.460 |
Why?
| | Calcium, Dietary | 1 | 2014 | 55 | 0.460 |
Why?
| | Communication Barriers | 2 | 2007 | 90 | 0.450 |
Why?
| | Endothelium | 1 | 2014 | 115 | 0.450 |
Why?
| | Nitric Oxide | 4 | 2003 | 833 | 0.420 |
Why?
| | Altitude | 5 | 2004 | 409 | 0.420 |
Why?
| | Arthritis, Psoriatic | 5 | 2000 | 16 | 0.420 |
Why?
| | Fibromyalgia | 4 | 2009 | 56 | 0.420 |
Why?
| | Humans | 153 | 2015 | 115859 | 0.410 |
Why?
| | Arteries | 1 | 2014 | 250 | 0.400 |
Why?
| | Male | 90 | 2015 | 56103 | 0.400 |
Why?
| | Aged | 55 | 2015 | 19292 | 0.390 |
Why?
| | Adult | 72 | 2015 | 30814 | 0.390 |
Why?
| | Low Back Pain | 3 | 1998 | 95 | 0.380 |
Why?
| | Rheumatic Diseases | 2 | 2010 | 49 | 0.370 |
Why?
| | Dietary Supplements | 1 | 2014 | 460 | 0.360 |
Why?
| | Medical Order Entry Systems | 1 | 2010 | 41 | 0.340 |
Why?
| | Travel | 2 | 2008 | 121 | 0.330 |
Why?
| | Gold | 6 | 1997 | 107 | 0.330 |
Why?
| | Israel | 11 | 2010 | 37 | 0.320 |
Why?
| | Prostaglandins E | 6 | 1993 | 46 | 0.320 |
Why?
| | Physical Examination | 3 | 2015 | 224 | 0.320 |
Why?
| | Aurothioglucose | 3 | 1997 | 6 | 0.310 |
Why?
| | Antirheumatic Agents | 5 | 2006 | 255 | 0.310 |
Why?
| | Drug Eruptions | 3 | 1997 | 26 | 0.300 |
Why?
| | Knee Joint | 5 | 2003 | 325 | 0.300 |
Why?
| | Sleep Wake Disorders | 2 | 2004 | 233 | 0.290 |
Why?
| | Spondylitis, Ankylosing | 4 | 2007 | 43 | 0.290 |
Why?
| | Severity of Illness Index | 4 | 2007 | 2590 | 0.290 |
Why?
| | Matrix Metalloproteinase 3 | 2 | 2006 | 23 | 0.290 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 6 | 2003 | 301 | 0.280 |
Why?
| | Child Behavior | 2 | 2007 | 218 | 0.280 |
Why?
| | Professional-Family Relations | 1 | 2008 | 138 | 0.270 |
Why?
| | Tumor Necrosis Factor-alpha | 4 | 2004 | 1137 | 0.270 |
Why?
| | Penicillamine | 5 | 1991 | 22 | 0.270 |
Why?
| | Wilderness | 2 | 2015 | 15 | 0.260 |
Why?
| | Child Welfare | 1 | 2008 | 198 | 0.260 |
Why?
| | Length of Stay | 1 | 2010 | 960 | 0.260 |
Why?
| | Lupus Erythematosus, Systemic | 9 | 2003 | 222 | 0.250 |
Why?
| | Receptors, Interleukin-2 | 3 | 2000 | 65 | 0.250 |
Why?
| | Sensitivity and Specificity | 7 | 2010 | 1725 | 0.250 |
Why?
| | Health Education | 1 | 2008 | 317 | 0.250 |
Why?
| | Tomography, X-Ray Computed | 8 | 1998 | 2404 | 0.240 |
Why?
| | Emergency Service, Hospital | 3 | 2010 | 1842 | 0.230 |
Why?
| | Heat Stroke | 1 | 2004 | 6 | 0.230 |
Why?
| | Population Surveillance | 1 | 2007 | 395 | 0.230 |
Why?
| | Hydroxybutyrates | 1 | 2003 | 10 | 0.220 |
Why?
| | Osteoarthritis, Knee | 2 | 2003 | 213 | 0.220 |
Why?
| | Phytotherapy | 1 | 2003 | 66 | 0.220 |
Why?
| | Aniline Compounds | 1 | 2003 | 71 | 0.220 |
Why?
| | Anthraquinones | 2 | 2000 | 9 | 0.220 |
Why?
| | Cervical Vertebrae | 2 | 1995 | 104 | 0.220 |
Why?
| | Fibroblasts | 7 | 1993 | 838 | 0.210 |
Why?
| | Prednisone | 8 | 2003 | 232 | 0.210 |
Why?
| | Osteonecrosis | 2 | 1996 | 19 | 0.210 |
Why?
| | Wounds and Injuries | 5 | 2015 | 731 | 0.200 |
Why?
| | Respiration | 1 | 2003 | 180 | 0.200 |
Why?
| | Mud Therapy | 3 | 2000 | 3 | 0.200 |
Why?
| | Plant Extracts | 1 | 2003 | 153 | 0.200 |
Why?
| | Prospective Studies | 15 | 2004 | 6276 | 0.200 |
Why?
| | Receptors, Interleukin-1 | 2 | 2001 | 227 | 0.200 |
Why?
| | Dinoprostone | 2 | 1999 | 188 | 0.200 |
Why?
| | Hydroxychloroquine | 2 | 1999 | 55 | 0.200 |
Why?
| | Minocycline | 5 | 1999 | 26 | 0.190 |
Why?
| | Guanidines | 1 | 2001 | 33 | 0.190 |
Why?
| | Retinal Hemorrhage | 1 | 2001 | 18 | 0.190 |
Why?
| | Back Pain | 3 | 2000 | 44 | 0.190 |
Why?
| | Hand | 5 | 2001 | 135 | 0.180 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2014 | 1871 | 0.180 |
Why?
| | Pulmonary Edema | 1 | 2001 | 116 | 0.180 |
Why?
| | Nitric Oxide Synthase | 1 | 2001 | 213 | 0.180 |
Why?
| | Arthritis, Juvenile | 2 | 1992 | 42 | 0.180 |
Why?
| | Amitriptyline | 1 | 1999 | 21 | 0.170 |
Why?
| | Aged, 80 and over | 13 | 2010 | 6434 | 0.170 |
Why?
| | Adrenal Cortex Hormones | 3 | 1999 | 510 | 0.170 |
Why?
| | Synovial Fluid | 2 | 1989 | 57 | 0.170 |
Why?
| | Emergency Treatment | 2 | 2004 | 115 | 0.170 |
Why?
| | Fluoxetine | 1 | 1999 | 46 | 0.170 |
Why?
| | Calcinosis | 3 | 1998 | 244 | 0.170 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2008 | 1193 | 0.170 |
Why?
| | Resuscitation | 2 | 1994 | 248 | 0.170 |
Why?
| | Biomarkers | 12 | 2000 | 3474 | 0.160 |
Why?
| | Tears | 1 | 1998 | 14 | 0.160 |
Why?
| | Immunosuppressive Agents | 1 | 2003 | 666 | 0.160 |
Why?
| | Antiphospholipid Syndrome | 2 | 1998 | 26 | 0.160 |
Why?
| | Analgesia, Epidural | 1 | 1998 | 20 | 0.160 |
Why?
| | Down-Regulation | 1 | 2001 | 605 | 0.160 |
Why?
| | Eye Proteins | 1 | 1998 | 74 | 0.160 |
Why?
| | Cross-Over Studies | 2 | 2014 | 437 | 0.150 |
Why?
| | Pain Measurement | 5 | 2004 | 449 | 0.150 |
Why?
| | Disasters | 1 | 1999 | 88 | 0.150 |
Why?
| | Enzyme Inhibitors | 1 | 2001 | 758 | 0.150 |
Why?
| | Hypoxia | 1 | 2004 | 937 | 0.150 |
Why?
| | Acute Disease | 6 | 2007 | 917 | 0.150 |
Why?
| | Osteoporosis | 2 | 1999 | 227 | 0.150 |
Why?
| | RNA, Small Cytoplasmic | 1 | 1997 | 6 | 0.140 |
Why?
| | Ultraviolet Rays | 1 | 2000 | 372 | 0.140 |
Why?
| | Bronchial Spasm | 1 | 1996 | 7 | 0.140 |
Why?
| | Anti-Inflammatory Agents | 4 | 2003 | 447 | 0.140 |
Why?
| | Mortality | 1 | 1999 | 290 | 0.140 |
Why?
| | Capnography | 1 | 1996 | 11 | 0.140 |
Why?
| | Antibodies, Antiphospholipid | 1 | 1996 | 21 | 0.140 |
Why?
| | Disabled Persons | 2 | 2015 | 135 | 0.140 |
Why?
| | Sulfasalazine | 2 | 1997 | 21 | 0.140 |
Why?
| | Rheumatoid Nodule | 3 | 2001 | 6 | 0.130 |
Why?
| | C-Reactive Protein | 5 | 1999 | 364 | 0.130 |
Why?
| | Thermometers | 1 | 1995 | 6 | 0.130 |
Why?
| | Eicosanoids | 1 | 1996 | 56 | 0.130 |
Why?
| | Brown-Sequard Syndrome | 1 | 1995 | 5 | 0.130 |
Why?
| | Autoimmune Diseases | 4 | 2000 | 396 | 0.130 |
Why?
| | Thermography | 1 | 1995 | 12 | 0.130 |
Why?
| | Tympanic Membrane | 1 | 1995 | 20 | 0.130 |
Why?
| | Cyanoacrylates | 1 | 1995 | 4 | 0.130 |
Why?
| | Medical History Taking | 1 | 2015 | 115 | 0.130 |
Why?
| | Mountaineering | 3 | 2008 | 45 | 0.130 |
Why?
| | HLA Antigens | 5 | 1991 | 224 | 0.130 |
Why?
| | Joint Deformities, Acquired | 2 | 2000 | 10 | 0.130 |
Why?
| | Tissue Adhesives | 1 | 1995 | 17 | 0.130 |
Why?
| | Foot Ulcer | 1 | 1995 | 5 | 0.130 |
Why?
| | Creatinine | 3 | 2014 | 431 | 0.130 |
Why?
| | Jews | 5 | 2009 | 19 | 0.130 |
Why?
| | Colitis, Ulcerative | 1 | 1996 | 106 | 0.120 |
Why?
| | HLA-DR Antigens | 2 | 1994 | 220 | 0.120 |
Why?
| | Hospital Design and Construction | 1 | 1994 | 3 | 0.120 |
Why?
| | Hand Injuries | 1 | 1995 | 33 | 0.120 |
Why?
| | Fever | 2 | 1996 | 280 | 0.120 |
Why?
| | Lacerations | 1 | 1995 | 30 | 0.120 |
Why?
| | Administration, Oral | 3 | 2014 | 733 | 0.120 |
Why?
| | Glycosaminoglycans | 2 | 1999 | 80 | 0.120 |
Why?
| | Cartilage, Articular | 3 | 2001 | 291 | 0.120 |
Why?
| | Wounds, Penetrating | 1 | 1995 | 72 | 0.120 |
Why?
| | Joints | 4 | 2004 | 84 | 0.120 |
Why?
| | Recommended Dietary Allowances | 1 | 2014 | 17 | 0.120 |
Why?
| | Hypersensitivity | 1 | 1998 | 272 | 0.120 |
Why?
| | Cells, Cultured | 7 | 2003 | 3914 | 0.120 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2003 | 796 | 0.120 |
Why?
| | Metacarpophalangeal Joint | 1 | 1993 | 11 | 0.120 |
Why?
| | Environment | 1 | 2015 | 340 | 0.110 |
Why?
| | Amyloidosis | 3 | 1988 | 36 | 0.110 |
Why?
| | Androgen-Insensitivity Syndrome | 1 | 2013 | 6 | 0.110 |
Why?
| | Phosphorus | 1 | 2014 | 81 | 0.110 |
Why?
| | Parathyroid Hormone | 1 | 2014 | 95 | 0.110 |
Why?
| | Reference Values | 4 | 2007 | 745 | 0.110 |
Why?
| | Healthy Volunteers | 1 | 2014 | 191 | 0.110 |
Why?
| | Calcitriol | 1 | 1993 | 53 | 0.110 |
Why?
| | Colorado | 4 | 2010 | 4122 | 0.110 |
Why?
| | Random Allocation | 1 | 2014 | 337 | 0.110 |
Why?
| | Growth Inhibitors | 1 | 1993 | 45 | 0.110 |
Why?
| | Child, Preschool | 7 | 2007 | 9164 | 0.110 |
Why?
| | Wound Healing | 1 | 1995 | 262 | 0.110 |
Why?
| | Prevalence | 3 | 2010 | 2270 | 0.110 |
Why?
| | Time Factors | 12 | 2003 | 6182 | 0.110 |
Why?
| | Blood Sedimentation | 5 | 2000 | 34 | 0.100 |
Why?
| | Point Mutation | 1 | 2013 | 218 | 0.100 |
Why?
| | Synovitis | 4 | 1993 | 24 | 0.100 |
Why?
| | Radiography | 7 | 2001 | 826 | 0.100 |
Why?
| | Leukocytes | 4 | 2002 | 284 | 0.100 |
Why?
| | Acute-Phase Reaction | 2 | 1989 | 39 | 0.100 |
Why?
| | Leucovorin | 2 | 1990 | 42 | 0.100 |
Why?
| | Eye Diseases | 2 | 1992 | 76 | 0.100 |
Why?
| | Receptors, Androgen | 1 | 2013 | 132 | 0.100 |
Why?
| | Carpal Bones | 1 | 1992 | 14 | 0.100 |
Why?
| | Hyperemia | 1 | 1992 | 44 | 0.100 |
Why?
| | Ulna | 1 | 1992 | 27 | 0.100 |
Why?
| | Vitamin D | 2 | 2014 | 341 | 0.100 |
Why?
| | Erythema Nodosum | 1 | 1991 | 3 | 0.100 |
Why?
| | Measles virus | 2 | 1981 | 11 | 0.100 |
Why?
| | Rubella virus | 2 | 1981 | 6 | 0.100 |
Why?
| | Vasculitis | 3 | 2001 | 71 | 0.100 |
Why?
| | Spinal Injuries | 1 | 1992 | 48 | 0.100 |
Why?
| | Myocardial Infarction | 2 | 2014 | 932 | 0.100 |
Why?
| | Red-Cell Aplasia, Pure | 1 | 1991 | 1 | 0.100 |
Why?
| | Airway Obstruction | 2 | 1996 | 169 | 0.100 |
Why?
| | Reproducibility of Results | 3 | 2007 | 2807 | 0.100 |
Why?
| | Interleukin-10 | 2 | 2006 | 304 | 0.090 |
Why?
| | Microbial Collagenase | 1 | 1990 | 10 | 0.090 |
Why?
| | Child | 9 | 2015 | 18537 | 0.090 |
Why?
| | Urinary Tract Infections | 1 | 1992 | 136 | 0.090 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 1992 | 126 | 0.090 |
Why?
| | Treatment Outcome | 10 | 2004 | 9163 | 0.090 |
Why?
| | Heart Rate | 1 | 2014 | 700 | 0.090 |
Why?
| | Anti-Bacterial Agents | 5 | 2003 | 1486 | 0.090 |
Why?
| | Arthritis | 4 | 2000 | 110 | 0.090 |
Why?
| | Digital Rectal Examination | 1 | 2010 | 10 | 0.090 |
Why?
| | Occult Blood | 1 | 2010 | 27 | 0.090 |
Why?
| | Testosterone | 1 | 2013 | 336 | 0.090 |
Why?
| | Interferon-gamma | 2 | 1990 | 733 | 0.090 |
Why?
| | Infant | 6 | 2004 | 7992 | 0.090 |
Why?
| | Receptors, Neurokinin-1 | 1 | 2009 | 12 | 0.090 |
Why?
| | Jaundice | 1 | 1989 | 14 | 0.090 |
Why?
| | Diclofenac | 1 | 1989 | 14 | 0.090 |
Why?
| | Intervertebral Disc Displacement | 1 | 1990 | 36 | 0.080 |
Why?
| | Spinal Diseases | 1 | 1990 | 45 | 0.080 |
Why?
| | Ligaments, Articular | 1 | 1990 | 56 | 0.080 |
Why?
| | Dopamine Plasma Membrane Transport Proteins | 1 | 2009 | 40 | 0.080 |
Why?
| | Age Factors | 6 | 2015 | 2911 | 0.080 |
Why?
| | Temporomandibular Joint Disorders | 1 | 1989 | 9 | 0.080 |
Why?
| | Temporomandibular Joint | 1 | 1989 | 10 | 0.080 |
Why?
| | Aspirin | 2 | 2003 | 326 | 0.080 |
Why?
| | Anemia, Aplastic | 1 | 1989 | 29 | 0.080 |
Why?
| | Cryoglobulinemia | 1 | 1988 | 5 | 0.080 |
Why?
| | Keratosis | 1 | 1988 | 13 | 0.080 |
Why?
| | Biological Factors | 1 | 1989 | 37 | 0.080 |
Why?
| | Familial Mediterranean Fever | 1 | 1988 | 6 | 0.080 |
Why?
| | Ichthyosis | 1 | 1988 | 12 | 0.080 |
Why?
| | Lipopolysaccharides | 2 | 2003 | 832 | 0.080 |
Why?
| | Scleroderma, Systemic | 2 | 2000 | 97 | 0.080 |
Why?
| | Auranofin | 1 | 1988 | 9 | 0.080 |
Why?
| | alpha 1-Antitrypsin | 1 | 2009 | 110 | 0.080 |
Why?
| | Hydrocortisone | 3 | 2001 | 272 | 0.080 |
Why?
| | Immunoglobulins | 1 | 1988 | 148 | 0.080 |
Why?
| | Chyle | 1 | 1988 | 3 | 0.080 |
Why?
| | Stomatitis, Aphthous | 1 | 1988 | 10 | 0.080 |
Why?
| | Adolescent | 12 | 2015 | 17935 | 0.080 |
Why?
| | Seasons | 1 | 2010 | 450 | 0.080 |
Why?
| | Language | 1 | 2010 | 257 | 0.080 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 1988 | 72 | 0.080 |
Why?
| | Interviews as Topic | 1 | 2010 | 595 | 0.080 |
Why?
| | Ligaments | 1 | 1988 | 44 | 0.070 |
Why?
| | Peripheral Nervous System Diseases | 1 | 1988 | 120 | 0.070 |
Why?
| | Skin | 5 | 2003 | 668 | 0.070 |
Why?
| | Polychondritis, Relapsing | 1 | 1987 | 2 | 0.070 |
Why?
| | Double-Blind Method | 3 | 2003 | 1664 | 0.070 |
Why?
| | Academic Medical Centers | 1 | 2010 | 416 | 0.070 |
Why?
| | HLA-B27 Antigen | 1 | 2007 | 11 | 0.070 |
Why?
| | Joint Diseases | 1 | 1988 | 59 | 0.070 |
Why?
| | Edema | 1 | 1988 | 119 | 0.070 |
Why?
| | Cysts | 1 | 1988 | 94 | 0.070 |
Why?
| | Remission Induction | 3 | 1993 | 240 | 0.070 |
Why?
| | Chronic Disease | 4 | 2015 | 1598 | 0.070 |
Why?
| | Demography | 2 | 1999 | 264 | 0.070 |
Why?
| | Liver | 2 | 1992 | 1693 | 0.070 |
Why?
| | Evaluation Studies as Topic | 3 | 1999 | 170 | 0.070 |
Why?
| | Blood Proteins | 1 | 1988 | 238 | 0.070 |
Why?
| | Spine | 1 | 1988 | 141 | 0.070 |
Why?
| | Primary Prevention | 1 | 2008 | 170 | 0.070 |
Why?
| | Syndrome | 4 | 1993 | 339 | 0.070 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2006 | 22 | 0.070 |
Why?
| | Diagnosis, Differential | 4 | 2003 | 1359 | 0.070 |
Why?
| | Monitoring, Physiologic | 2 | 2004 | 252 | 0.070 |
Why?
| | Recombinant Proteins | 3 | 1997 | 1244 | 0.070 |
Why?
| | Shoulder Joint | 1 | 1988 | 160 | 0.070 |
Why?
| | Incidence | 3 | 2002 | 2336 | 0.070 |
Why?
| | Oxygen | 3 | 2003 | 837 | 0.060 |
Why?
| | Isoxazoles | 1 | 2006 | 56 | 0.060 |
Why?
| | Culture Techniques | 2 | 1999 | 80 | 0.060 |
Why?
| | Pedigree | 4 | 2000 | 474 | 0.060 |
Why?
| | Sports | 2 | 2015 | 175 | 0.060 |
Why?
| | Retrospective Studies | 9 | 2010 | 12615 | 0.060 |
Why?
| | Rheumatoid Factor | 2 | 2001 | 157 | 0.060 |
Why?
| | Kidney | 2 | 2003 | 1210 | 0.060 |
Why?
| | Combined Modality Therapy | 2 | 2000 | 1127 | 0.060 |
Why?
| | Inflammation | 3 | 1989 | 2502 | 0.060 |
Why?
| | Oximetry | 2 | 2003 | 80 | 0.060 |
Why?
| | Octreotide | 1 | 2004 | 25 | 0.060 |
Why?
| | Biopsy, Needle | 2 | 1999 | 183 | 0.060 |
Why?
| | Cell Division | 4 | 1993 | 760 | 0.060 |
Why?
| | Crohn Disease | 2 | 2004 | 197 | 0.060 |
Why?
| | Patient Discharge | 1 | 2010 | 770 | 0.060 |
Why?
| | Autoantibodies | 4 | 1999 | 1362 | 0.060 |
Why?
| | Crotonates | 1 | 2003 | 3 | 0.060 |
Why?
| | Toluidines | 1 | 2003 | 6 | 0.060 |
Why?
| | Tenosynovitis | 1 | 2003 | 12 | 0.060 |
Why?
| | Acne Vulgaris | 3 | 1998 | 20 | 0.060 |
Why?
| | Mycobacterium kansasii | 1 | 2003 | 14 | 0.060 |
Why?
| | Hypnosis | 1 | 1983 | 9 | 0.060 |
Why?
| | Follow-Up Studies | 3 | 1999 | 4443 | 0.050 |
Why?
| | Pemphigus | 1 | 1983 | 8 | 0.050 |
Why?
| | Tuberculosis, Miliary | 1 | 2003 | 5 | 0.050 |
Why?
| | Tuberculosis, Cutaneous | 1 | 2003 | 4 | 0.050 |
Why?
| | Carpal Tunnel Syndrome | 1 | 2003 | 27 | 0.050 |
Why?
| | Fasciitis | 1 | 1982 | 10 | 0.050 |
Why?
| | Wakefulness | 1 | 2004 | 128 | 0.050 |
Why?
| | Lip | 2 | 2001 | 20 | 0.050 |
Why?
| | Lipoproteins | 1 | 1983 | 162 | 0.050 |
Why?
| | Cell Survival | 2 | 2003 | 1024 | 0.050 |
Why?
| | Uric Acid | 2 | 2003 | 150 | 0.050 |
Why?
| | History, 20th Century | 1 | 2004 | 275 | 0.050 |
Why?
| | Respiratory Function Tests | 2 | 2003 | 539 | 0.050 |
Why?
| | Tidal Volume | 1 | 2003 | 74 | 0.050 |
Why?
| | Technetium Tc 99m Exametazime | 1 | 2002 | 2 | 0.050 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2003 | 165 | 0.050 |
Why?
| | Spondylarthropathies | 1 | 2002 | 6 | 0.050 |
Why?
| | Athletes | 2 | 2015 | 323 | 0.050 |
Why?
| | Nitriles | 1 | 2003 | 152 | 0.050 |
Why?
| | Arthritis, Experimental | 1 | 2004 | 133 | 0.050 |
Why?
| | Radionuclide Imaging | 3 | 2002 | 121 | 0.050 |
Why?
| | Osteoporosis, Postmenopausal | 2 | 2000 | 36 | 0.050 |
Why?
| | Young Adult | 2 | 2015 | 10508 | 0.050 |
Why?
| | Biopsy | 2 | 1999 | 1056 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 2 | 2009 | 2201 | 0.050 |
Why?
| | Hepatitis B Vaccines | 1 | 2002 | 46 | 0.050 |
Why?
| | Newcastle disease virus | 1 | 1981 | 17 | 0.050 |
Why?
| | Adenoviruses, Human | 1 | 1981 | 24 | 0.050 |
Why?
| | Hepatitis B | 1 | 2002 | 53 | 0.050 |
Why?
| | Chi-Square Distribution | 2 | 2009 | 501 | 0.050 |
Why?
| | Complement C3b | 1 | 2001 | 30 | 0.050 |
Why?
| | Family Health | 2 | 1994 | 199 | 0.050 |
Why?
| | Movement | 1 | 2004 | 246 | 0.050 |
Why?
| | Immunocompromised Host | 1 | 2003 | 197 | 0.050 |
Why?
| | fas Receptor | 1 | 2001 | 93 | 0.050 |
Why?
| | Prednisolone | 2 | 1992 | 77 | 0.050 |
Why?
| | Carbon Dioxide | 1 | 2003 | 211 | 0.050 |
Why?
| | Emergencies | 2 | 1996 | 150 | 0.050 |
Why?
| | Nitroprusside | 1 | 2001 | 64 | 0.050 |
Why?
| | Radiopharmaceuticals | 1 | 2002 | 188 | 0.050 |
Why?
| | United States | 3 | 2008 | 12319 | 0.050 |
Why?
| | Cerebrovascular Circulation | 1 | 2003 | 202 | 0.050 |
Why?
| | Gastric Antral Vascular Ectasia | 1 | 2000 | 2 | 0.050 |
Why?
| | Hemoglobins | 1 | 2003 | 313 | 0.050 |
Why?
| | Eosinophilia | 1 | 1982 | 187 | 0.050 |
Why?
| | Xanthine | 1 | 2000 | 7 | 0.050 |
Why?
| | Pneumococcal Vaccines | 1 | 2001 | 132 | 0.050 |
Why?
| | Xanthine Dehydrogenase | 1 | 2000 | 26 | 0.050 |
Why?
| | Monocytes | 2 | 2001 | 504 | 0.050 |
Why?
| | Skiing | 1 | 2001 | 40 | 0.040 |
Why?
| | Salivary Glands | 2 | 1997 | 31 | 0.040 |
Why?
| | Leg | 2 | 1996 | 227 | 0.040 |
Why?
| | Sulfur Radioisotopes | 1 | 1999 | 17 | 0.040 |
Why?
| | Anxiety Disorders | 1 | 1983 | 310 | 0.040 |
Why?
| | Neck Pain | 1 | 2000 | 22 | 0.040 |
Why?
| | Lipids | 1 | 1983 | 589 | 0.040 |
Why?
| | Fractures, Stress | 1 | 2000 | 32 | 0.040 |
Why?
| | Haplotypes | 2 | 1992 | 475 | 0.040 |
Why?
| | Antidepressive Agents, Tricyclic | 1 | 1999 | 29 | 0.040 |
Why?
| | Analysis of Variance | 1 | 2003 | 1227 | 0.040 |
Why?
| | Glucocorticoids | 2 | 2001 | 551 | 0.040 |
Why?
| | HLA-DR4 Antigen | 2 | 1992 | 76 | 0.040 |
Why?
| | DNA, Viral | 1 | 1981 | 351 | 0.040 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 1999 | 38 | 0.040 |
Why?
| | Sialoglycoproteins | 1 | 2000 | 158 | 0.040 |
Why?
| | Age of Onset | 1 | 2001 | 455 | 0.040 |
Why?
| | Stimulation, Chemical | 2 | 1989 | 57 | 0.040 |
Why?
| | Alkaline Phosphatase | 2 | 1992 | 144 | 0.040 |
Why?
| | Xerostomia | 1 | 1999 | 19 | 0.040 |
Why?
| | Indomethacin | 2 | 1989 | 75 | 0.040 |
Why?
| | Hand Strength | 1 | 2000 | 97 | 0.040 |
Why?
| | Diagnostic Errors | 1 | 2000 | 151 | 0.040 |
Why?
| | Translations | 1 | 1999 | 16 | 0.040 |
Why?
| | Drug Administration Schedule | 2 | 1992 | 724 | 0.040 |
Why?
| | Sarcoidosis | 1 | 2001 | 134 | 0.040 |
Why?
| | Hemiplegia | 1 | 1998 | 19 | 0.040 |
Why?
| | Recurrence | 2 | 1992 | 950 | 0.040 |
Why?
| | Drug Synergism | 2 | 1990 | 316 | 0.040 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2000 | 123 | 0.040 |
Why?
| | Lumbosacral Region | 2 | 1990 | 46 | 0.040 |
Why?
| | Infant Behavior | 1 | 1998 | 23 | 0.040 |
Why?
| | Paresis | 1 | 1998 | 28 | 0.040 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2003 | 337 | 0.040 |
Why?
| | RNA, Viral | 1 | 1981 | 564 | 0.040 |
Why?
| | Health Status | 2 | 2004 | 727 | 0.040 |
Why?
| | Appetite | 1 | 1998 | 53 | 0.040 |
Why?
| | Prognosis | 2 | 1996 | 3344 | 0.040 |
Why?
| | Immunoglobulin A, Secretory | 1 | 1997 | 11 | 0.040 |
Why?
| | Antibodies, Monoclonal | 1 | 2004 | 1264 | 0.040 |
Why?
| | beta 2-Microglobulin | 1 | 1997 | 45 | 0.040 |
Why?
| | Lactoferrin | 1 | 1997 | 28 | 0.040 |
Why?
| | Electrolytes | 1 | 1997 | 55 | 0.040 |
Why?
| | Polymyalgia Rheumatica | 1 | 1997 | 2 | 0.040 |
Why?
| | Respiratory Hypersensitivity | 1 | 1998 | 63 | 0.040 |
Why?
| | Cartilage | 1 | 1999 | 182 | 0.040 |
Why?
| | Folic Acid Antagonists | 1 | 1997 | 8 | 0.040 |
Why?
| | Inflammatory Bowel Diseases | 2 | 2002 | 289 | 0.040 |
Why?
| | Appendicitis | 1 | 1998 | 110 | 0.040 |
Why?
| | Psoriasis | 2 | 2000 | 76 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 3 | 1998 | 3072 | 0.040 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 1998 | 93 | 0.040 |
Why?
| | Dermatitis, Allergic Contact | 1 | 1998 | 63 | 0.040 |
Why?
| | Forced Expiratory Flow Rates | 1 | 1996 | 12 | 0.040 |
Why?
| | Gene Frequency | 2 | 2009 | 506 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2002 | 1813 | 0.040 |
Why?
| | Histocompatibility Testing | 1 | 1997 | 116 | 0.030 |
Why?
| | Cohort Studies | 3 | 1998 | 4960 | 0.030 |
Why?
| | Drug Hypersensitivity | 1 | 1998 | 86 | 0.030 |
Why?
| | Pain Clinics | 1 | 1996 | 3 | 0.030 |
Why?
| | Drug Therapy, Combination | 3 | 2003 | 962 | 0.030 |
Why?
| | Chiropractic | 1 | 1996 | 6 | 0.030 |
Why?
| | Risk Assessment | 2 | 2015 | 2992 | 0.030 |
Why?
| | Patella | 1 | 1996 | 25 | 0.030 |
Why?
| | Thromboxane B2 | 1 | 1996 | 27 | 0.030 |
Why?
| | Ribonucleoproteins | 1 | 1997 | 87 | 0.030 |
Why?
| | Menopause | 1 | 1999 | 262 | 0.030 |
Why?
| | Risk Factors | 4 | 2015 | 8715 | 0.030 |
Why?
| | Acupuncture Therapy | 1 | 1996 | 18 | 0.030 |
Why?
| | Radioimmunoassay | 1 | 1996 | 163 | 0.030 |
Why?
| | Pilot Projects | 2 | 2004 | 1379 | 0.030 |
Why?
| | Mouth Diseases | 1 | 1996 | 38 | 0.030 |
Why?
| | Adrenergic beta-Agonists | 1 | 1996 | 129 | 0.030 |
Why?
| | Wilderness Medicine | 1 | 2015 | 12 | 0.030 |
Why?
| | Poliovirus Vaccine, Inactivated | 1 | 1995 | 22 | 0.030 |
Why?
| | Poliomyelitis | 1 | 1995 | 27 | 0.030 |
Why?
| | Abdomen | 2 | 2002 | 105 | 0.030 |
Why?
| | Mutation | 2 | 2009 | 3371 | 0.030 |
Why?
| | Thrombophlebitis | 1 | 1995 | 8 | 0.030 |
Why?
| | Reference Standards | 1 | 1995 | 162 | 0.030 |
Why?
| | Maintenance and Engineering, Hospital | 1 | 1994 | 2 | 0.030 |
Why?
| | Macrophages | 1 | 2001 | 1282 | 0.030 |
Why?
| | Rectum | 1 | 1995 | 151 | 0.030 |
Why?
| | Cholesterol | 2 | 1988 | 368 | 0.030 |
Why?
| | Antibodies, Antineutrophil Cytoplasmic | 3 | 1999 | 33 | 0.030 |
Why?
| | Angiography | 1 | 1995 | 177 | 0.030 |
Why?
| | Blotting, Western | 1 | 1997 | 1153 | 0.030 |
Why?
| | Autoantigens | 1 | 1997 | 399 | 0.030 |
Why?
| | 24,25-Dihydroxyvitamin D 3 | 1 | 1993 | 2 | 0.030 |
Why?
| | Parents | 1 | 2002 | 1208 | 0.030 |
Why?
| | Pregnancy | 3 | 2015 | 5555 | 0.030 |
Why?
| | Semen Analysis | 1 | 2013 | 10 | 0.030 |
Why?
| | Sperm Count | 1 | 2013 | 16 | 0.030 |
Why?
| | Sperm Injections, Intracytoplasmic | 1 | 2013 | 7 | 0.030 |
Why?
| | Food Hypersensitivity | 1 | 1998 | 254 | 0.030 |
Why?
| | Ischemia | 1 | 1996 | 363 | 0.030 |
Why?
| | Analgesics | 1 | 1995 | 157 | 0.030 |
Why?
| | Rats | 3 | 2004 | 5035 | 0.030 |
Why?
| | Hyperostosis, Sternocostoclavicular | 1 | 1993 | 1 | 0.030 |
Why?
| | Infertility, Male | 1 | 2013 | 60 | 0.030 |
Why?
| | Collagenases | 1 | 1993 | 22 | 0.030 |
Why?
| | Sleep | 1 | 1998 | 625 | 0.030 |
Why?
| | Linear Models | 1 | 1995 | 777 | 0.030 |
Why?
| | Apoptosis | 1 | 2001 | 2377 | 0.030 |
Why?
| | Cervical Atlas | 1 | 1992 | 6 | 0.030 |
Why?
| | Axis, Cervical Vertebra | 1 | 1992 | 9 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2013 | 267 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 1995 | 677 | 0.030 |
Why?
| | Transaminases | 1 | 1992 | 25 | 0.030 |
Why?
| | Blood Urea Nitrogen | 2 | 2003 | 51 | 0.030 |
Why?
| | Radius | 1 | 1992 | 33 | 0.030 |
Why?
| | Respiratory Tract Diseases | 1 | 1993 | 142 | 0.030 |
Why?
| | Atmosphere Exposure Chambers | 1 | 1991 | 6 | 0.030 |
Why?
| | Collagen | 2 | 1991 | 415 | 0.030 |
Why?
| | Serotyping | 1 | 1991 | 28 | 0.020 |
Why?
| | Hyperbaric Oxygenation | 1 | 1991 | 37 | 0.020 |
Why?
| | Pain | 2 | 2001 | 712 | 0.020 |
Why?
| | Infant, Premature | 1 | 1995 | 477 | 0.020 |
Why?
| | Kidney Function Tests | 2 | 2003 | 141 | 0.020 |
Why?
| | Adaptation, Physiological | 1 | 1995 | 477 | 0.020 |
Why?
| | Logistic Models | 1 | 1996 | 1863 | 0.020 |
Why?
| | Disease Models, Animal | 2 | 2004 | 3587 | 0.020 |
Why?
| | Drug Antagonism | 1 | 1990 | 8 | 0.020 |
Why?
| | Crystallization | 2 | 1988 | 138 | 0.020 |
Why?
| | Anticoagulants | 1 | 1995 | 549 | 0.020 |
Why?
| | Dyspnea | 1 | 1992 | 224 | 0.020 |
Why?
| | Antibody Formation | 3 | 2002 | 274 | 0.020 |
Why?
| | Self Concept | 1 | 1991 | 218 | 0.020 |
Why?
| | Spinal Stenosis | 1 | 1990 | 24 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 1995 | 2262 | 0.020 |
Why?
| | Drug Combinations | 1 | 1990 | 289 | 0.020 |
Why?
| | Asthma | 3 | 2003 | 2150 | 0.020 |
Why?
| | Etidronic Acid | 2 | 1999 | 3 | 0.020 |
Why?
| | Mandibular Condyle | 1 | 1989 | 5 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 1989 | 204 | 0.020 |
Why?
| | Smoking | 1 | 1996 | 1465 | 0.020 |
Why?
| | Congo Red | 1 | 1988 | 8 | 0.020 |
Why?
| | Accidents | 1 | 1989 | 40 | 0.020 |
Why?
| | Raynaud Disease | 1 | 1988 | 5 | 0.020 |
Why?
| | Infant, Newborn | 3 | 2013 | 5084 | 0.020 |
Why?
| | HLA-A Antigens | 2 | 1993 | 50 | 0.020 |
Why?
| | HLA-B35 Antigen | 1 | 1988 | 3 | 0.020 |
Why?
| | Azathioprine | 2 | 1992 | 50 | 0.020 |
Why?
| | Periarthritis | 1 | 1988 | 1 | 0.020 |
Why?
| | Staining and Labeling | 1 | 1988 | 139 | 0.020 |
Why?
| | Point-of-Care Systems | 1 | 2010 | 150 | 0.020 |
Why?
| | Immunoglobulin G | 2 | 2001 | 782 | 0.020 |
Why?
| | Serum Amyloid P-Component | 1 | 1987 | 3 | 0.020 |
Why?
| | Calcium Phosphates | 1 | 1988 | 25 | 0.020 |
Why?
| | Coronary Disease | 2 | 1995 | 348 | 0.020 |
Why?
| | Complement C4 | 1 | 1987 | 26 | 0.020 |
Why?
| | Vaccination | 1 | 1995 | 1209 | 0.020 |
Why?
| | Population | 1 | 2007 | 28 | 0.020 |
Why?
| | Accidental Falls | 1 | 1989 | 151 | 0.020 |
Why?
| | Odds Ratio | 1 | 2009 | 968 | 0.020 |
Why?
| | Alleles | 1 | 2009 | 817 | 0.020 |
Why?
| | Intubation, Intratracheal | 1 | 1988 | 216 | 0.020 |
Why?
| | Aging | 1 | 2015 | 1635 | 0.020 |
Why?
| | Iran | 2 | 2000 | 35 | 0.020 |
Why?
| | Hereditary Sensory and Autonomic Neuropathies | 1 | 1985 | 3 | 0.020 |
Why?
| | Radiography, Thoracic | 1 | 1986 | 165 | 0.020 |
Why?
| | Pyoderma Gangrenosum | 1 | 2004 | 5 | 0.020 |
Why?
| | Adipose Tissue | 1 | 1988 | 553 | 0.020 |
Why?
| | Cytokines | 2 | 1990 | 1858 | 0.020 |
Why?
| | Rats, Inbred Lew | 1 | 2004 | 93 | 0.010 |
Why?
| | Infliximab | 1 | 2004 | 94 | 0.010 |
Why?
| | Animals | 6 | 2004 | 32158 | 0.010 |
Why?
| | Injections, Intramuscular | 1 | 2004 | 118 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 1991 | 1758 | 0.010 |
Why?
| | Bone Marrow Examination | 1 | 1982 | 7 | 0.010 |
Why?
| | Debridement | 1 | 2003 | 75 | 0.010 |
Why?
| | Hypergammaglobulinemia | 1 | 1982 | 9 | 0.010 |
Why?
| | Finger Joint | 1 | 1982 | 7 | 0.010 |
Why?
| | Splenomegaly | 1 | 1982 | 18 | 0.010 |
Why?
| | Measles Vaccine | 1 | 1982 | 17 | 0.010 |
Why?
| | Genome-Wide Association Study | 1 | 2009 | 1277 | 0.010 |
Why?
| | Hepatitis B Antibodies | 1 | 2002 | 10 | 0.010 |
Why?
| | Hepatitis B Surface Antigens | 1 | 2002 | 19 | 0.010 |
Why?
| | Proteinuria | 1 | 1982 | 78 | 0.010 |
Why?
| | Myositis | 1 | 1982 | 43 | 0.010 |
Why?
| | Serologic Tests | 1 | 2002 | 51 | 0.010 |
Why?
| | Measles | 1 | 1982 | 38 | 0.010 |
Why?
| | Phospholipids | 1 | 1983 | 202 | 0.010 |
Why?
| | Elbow Joint | 1 | 1982 | 60 | 0.010 |
Why?
| | Arthritis, Infectious | 1 | 1982 | 50 | 0.010 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2003 | 334 | 0.010 |
Why?
| | Opsonin Proteins | 1 | 2001 | 25 | 0.010 |
Why?
| | Disease Susceptibility | 1 | 1983 | 321 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2009 | 2004 | 0.010 |
Why?
| | Triglycerides | 1 | 1983 | 471 | 0.010 |
Why?
| | Chondrocalcinosis | 1 | 2001 | 2 | 0.010 |
Why?
| | Receptors, Complement | 1 | 2001 | 112 | 0.010 |
Why?
| | Clinical Chemistry Tests | 1 | 2001 | 9 | 0.010 |
Why?
| | Occupations | 1 | 2001 | 36 | 0.010 |
Why?
| | Hematologic Tests | 1 | 2001 | 22 | 0.010 |
Why?
| | Antibodies, Bacterial | 1 | 2001 | 119 | 0.010 |
Why?
| | Anemia, Hypochromic | 1 | 2000 | 3 | 0.010 |
Why?
| | Thyroid Diseases | 1 | 2001 | 30 | 0.010 |
Why?
| | Reoperation | 1 | 2003 | 525 | 0.010 |
Why?
| | Therapeutic Equivalency | 1 | 2000 | 18 | 0.010 |
Why?
| | Ankle Joint | 1 | 1982 | 155 | 0.010 |
Why?
| | Pneumococcal Infections | 1 | 2001 | 91 | 0.010 |
Why?
| | Histocompatibility Antigens Class II | 1 | 1982 | 352 | 0.010 |
Why?
| | Thymus Gland | 1 | 2001 | 298 | 0.010 |
Why?
| | Polymorphism, Single-Stranded Conformational | 1 | 2000 | 29 | 0.010 |
Why?
| | Amino Acid Sequence | 2 | 2000 | 2003 | 0.010 |
Why?
| | Laser Coagulation | 1 | 2000 | 54 | 0.010 |
Why?
| | Placebos | 1 | 2000 | 198 | 0.010 |
Why?
| | Furosemide | 1 | 2000 | 32 | 0.010 |
Why?
| | Microsatellite Repeats | 1 | 2000 | 140 | 0.010 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2000 | 102 | 0.010 |
Why?
| | Folic Acid | 2 | 1990 | 159 | 0.010 |
Why?
| | Diuretics | 1 | 2000 | 67 | 0.010 |
Why?
| | Serum Sickness | 1 | 1999 | 7 | 0.010 |
Why?
| | Genetic Linkage | 1 | 2000 | 314 | 0.010 |
Why?
| | Endoscopy, Digestive System | 1 | 2000 | 109 | 0.010 |
Why?
| | Calcitonin | 1 | 1999 | 23 | 0.010 |
Why?
| | Antibodies, Anticardiolipin | 1 | 1998 | 5 | 0.010 |
Why?
| | Neoplasms | 1 | 1993 | 2114 | 0.010 |
Why?
| | Serum Albumin | 1 | 2000 | 135 | 0.010 |
Why?
| | Hepatitis, Autoimmune | 1 | 1999 | 32 | 0.010 |
Why?
| | Iatrogenic Disease | 1 | 1999 | 51 | 0.010 |
Why?
| | Gene Expression | 1 | 2004 | 1442 | 0.010 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2000 | 254 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2000 | 515 | 0.010 |
Why?
| | Appendectomy | 1 | 1998 | 61 | 0.010 |
Why?
| | Arthralgia | 1 | 1998 | 50 | 0.010 |
Why?
| | Kinetics | 1 | 2001 | 1568 | 0.010 |
Why?
| | Estrogen Replacement Therapy | 1 | 1999 | 116 | 0.010 |
Why?
| | Data Interpretation, Statistical | 1 | 2000 | 325 | 0.010 |
Why?
| | Functional Laterality | 1 | 1998 | 201 | 0.010 |
Why?
| | Laparotomy | 1 | 1998 | 97 | 0.010 |
Why?
| | Cell Aggregation | 2 | 1988 | 24 | 0.010 |
Why?
| | Occupational Diseases | 1 | 1998 | 129 | 0.010 |
Why?
| | Sacroiliac Joint | 1 | 1997 | 31 | 0.010 |
Why?
| | Skin Diseases, Vascular | 1 | 1996 | 8 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2004 | 2581 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2003 | 3054 | 0.010 |
Why?
| | Base Sequence | 1 | 2000 | 2121 | 0.010 |
Why?
| | Peroxidase | 1 | 1996 | 157 | 0.010 |
Why?
| | Sex Factors | 1 | 2001 | 1741 | 0.010 |
Why?
| | Infant Welfare | 1 | 1995 | 4 | 0.010 |
Why?
| | Bone Density | 1 | 1999 | 432 | 0.010 |
Why?
| | Vaccines, Inactivated | 1 | 1995 | 68 | 0.010 |
Why?
| | Spirometry | 1 | 1995 | 256 | 0.010 |
Why?
| | Europe | 1 | 1994 | 343 | 0.010 |
Why?
| | Body Mass Index | 1 | 2000 | 1974 | 0.010 |
Why?
| | Osteomyelitis | 1 | 1993 | 105 | 0.010 |
Why?
| | Necrosis | 1 | 1972 | 211 | 0.010 |
Why?
| | Endopeptidases | 1 | 1990 | 72 | 0.010 |
Why?
| | Prostheses and Implants | 1 | 1972 | 141 | 0.010 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 1991 | 129 | 0.010 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2003 | 2090 | 0.010 |
Why?
| | Lymphoma | 1 | 1990 | 177 | 0.010 |
Why?
| | Depression, Chemical | 1 | 1989 | 23 | 0.010 |
Why?
| | Interleukin-2 | 1 | 1990 | 416 | 0.010 |
Why?
| | Drug Interactions | 1 | 1990 | 347 | 0.010 |
Why?
| | Health Promotion | 1 | 1995 | 690 | 0.010 |
Why?
| | Immunity, Cellular | 1 | 1990 | 263 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1990 | 850 | 0.010 |
Why?
| | Mice | 3 | 1990 | 15085 | 0.010 |
Why?
| | Multiple Trauma | 1 | 1989 | 91 | 0.000 |
Why?
| | Lung Diseases | 1 | 1995 | 710 | 0.000 |
Why?
| | Arthrography | 1 | 1988 | 22 | 0.000 |
Why?
| | Injections, Subcutaneous | 1 | 1987 | 137 | 0.000 |
Why?
| | Iodine Radioisotopes | 1 | 1987 | 126 | 0.000 |
Why?
| | Hemodynamics | 1 | 1991 | 969 | 0.000 |
Why?
| | Tissue Distribution | 1 | 1987 | 324 | 0.000 |
Why?
| | Cell Adhesion | 1 | 1988 | 433 | 0.000 |
Why?
| | Hypertension | 1 | 1995 | 1065 | 0.000 |
Why?
| | Suicide, Attempted | 1 | 1989 | 316 | 0.000 |
Why?
| | Poland | 1 | 1985 | 28 | 0.000 |
Why?
| | Bacterial Infections | 1 | 1987 | 222 | 0.000 |
Why?
| | Virus Diseases | 1 | 1987 | 200 | 0.000 |
Why?
| | Vitreous Body | 1 | 1985 | 102 | 0.000 |
Why?
| | Amyloid | 1 | 1985 | 82 | 0.000 |
Why?
| | Preoperative Care | 1 | 1986 | 318 | 0.000 |
Why?
| | Tuberculosis | 1 | 1986 | 244 | 0.000 |
Why?
| | HLA-DR1 Antigen | 1 | 1982 | 1 | 0.000 |
Why?
| | Injections, Intra-Articular | 1 | 1982 | 45 | 0.000 |
Why?
| | Rats, Inbred Strains | 1 | 1982 | 376 | 0.000 |
Why?
| | Lung Neoplasms | 1 | 1986 | 2206 | 0.000 |
Why?
| | Methods | 1 | 1972 | 59 | 0.000 |
Why?
| | Knee | 1 | 1972 | 50 | 0.000 |
Why?
|
|
Yaron's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|